ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

HLA Specific Antibody Levels after EDTA Treatment in CDC Crossmatch Positive and Negative Sera with Known Donor-Specific Antibodies

J. Lauronen1, T. Jaatinen1, J. Holgersson2, C. Naper3, J. Peräsaari1

1Histocompatibility Laboratory, Finnish Red Cross Blood Service, Helsinki, Finland, 2Department of Laboratory Medicine, Sahlgrenska Academy at University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden, 3Histocompatibility Laboratory, Oslo University Hospital, Oslo, Norway

Meeting: 2020 American Transplant Congress

Abstract number: A-284

Keywords: Antibodies, Histocompatibility, Histocompatibility antigens, HLA antibodies

Session Information

Date: Saturday, May 30, 2020

Session Name: Poster Session A: Histocompatibility and Immunogenetics

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

Related Abstracts
  • Evaluation of FlowDSA Crossmatch for Detection of Donor-Specific HLA Antibodies
  • Probability of a Positive AHG-CDC Crossmatch Is Determined by the Number, Strength, and Specificity of Donor-Specific Antibodies

*Purpose: Ethylenediaminetetraacetic acid (EDTA) treatment of serum samples overcomes the prozone effect that may interfere with solid phase HLA specific antibody analyses. In patients with platelet refractoriness we have seen that EDTA leads to increased mean fluorescence intensity (MFI) of most detected antibodies. We analyzed the effect of EDTA treatment on selected serum samples with known donor-specific antibodies (DSA) that tested either negative or positive in complement dependent cytotoxic crossmatch (CDC) tests. We hypothesized that the antibodies were stronger in CDC positive as compared to negative sera, and that the true MFI levels of these antibodies were disguised by the prozone effect.

*Methods: 60 DSA positive (30 CDC positive, 30 CDC negative) serum samples from sensitized patients on the kidney transplant waiting lists were analyzed. Samples were collected from Finnish Red Cross Blood Service, Sahlgrenska University Hospital and Oslo University Hospital. Analyses of HLA antibodies were performed in Helsinki with and without EDTA using LABScreen™ Single Antigen kits (One Lambda, Thermo Fisher) in the Luminex and with the Fusion 4.2 software. A mean MFI increase of more than 1000 was considered significant.

*Results: The MFI levels of native sera were higher in CDC positive [sum (range) of each bead MFI means; 76933 (6850-253042)] as compared to CDC negative cases [31169 (4865-132994)]. There was no statistically significant difference between the MFI levels of EDTA-treated and native sera in any of the detected antibody specifities [sum (range) of MFI means of EDTA treated samples were 30878 (4582-136908) and 78465 (5726-260221) in CDC negative and positive, respectively]. None of the detected antibody MFI means increased >1000 MFI; change was between -174 to 255 in CDC negative and -132 to 369 in CDC positive sera. Interestingly, the mean MFI levels increased slightly with EDTA treatment in 76/97 HLA class I antibodies of CDC positive cases as compared to only 19/97 of the CDC negative cases (p>0,001).

*Conclusions: The MFI levels of HLA specific antibodies were higher in CDC positive as compared to CDC negative patients. The MFI levels did not change drastically after EDTA treatment, although a slight increase was observed for many HLA class I specific antibodies in CDC positive cases.

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Lauronen J, Jaatinen T, Holgersson J, Naper C, Peräsaari J. HLA Specific Antibody Levels after EDTA Treatment in CDC Crossmatch Positive and Negative Sera with Known Donor-Specific Antibodies [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/hla-specific-antibody-levels-after-edta-treatment-in-cdc-crossmatch-positive-and-negative-sera-with-known-donor-specific-antibodies/. Accessed January 27, 2021.

« Back to 2020 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.

    Visit Our Partner Sites

    American Transplant Congress (ATC)

    Visit the official site for the American Transplant Congress »

    American Journal of Transplantation

    The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

    American Society of Transplantation (AST)

    An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

    American Society of Transplant Surgeons (ASTS)

    The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

    Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

    Privacy Policy

    loading Cancel
    Post was not sent - check your email addresses!
    Email check failed, please try again
    Sorry, your blog cannot share posts by email.
    This site uses cookies: Find out more.